Avricore Health Completes $1.54 Million Financing and Grants Options
VANCOUVER, British Columbia, Feb. 12, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces it...
Day: February 12, 2021
George Archos Reports Holdings in Verano Holdings Corp.
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- George Archos (the “Acquiror”), the Chairman, CEO and a director of Verano Holdings...
Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
BASKING RIDGE, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage...
Smile Direct Club to Report Fourth Quarter and Year End 2020 Results on March 4, 2021
NASHVILLE, Tenn., Feb. 12, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the...
Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors
CAMBRIDGE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
BridgeBio Pharma, Inc. Announces Pricing of Secondary Offering of Common Stock
PALO ALTO, Calif. , Feb. 12, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”)...
Denali Therapeutics Reports Positive Three-Month Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with Hunter Syndrome (MPS II)
Sustained normalization and further decreased levels of CSF glycosaminoglycan heparan sulfate, a key CNS disease biomarker, observed after three months...
SMFM Conference and Publications Highlight the Challenges and Complexities of Diagnosing and Managing Preeclampsia
Progenity applauds focus on preeclampsia biomarkers as it prepares for the launch of the Preecludia™ testSAN DIEGO, Feb. 12, 2021...
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa
TYG100 utilizes proprietary S-TIR™ technology platform enabling specific B cell and T cell responses against tumor antigensFOSTER CITY, Calif. and...
OncXerna Therapeutics to Participate at the Upcoming Investor Conferences
WALTHAM, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-based biomarker...
New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate Cancer
Results from second study cite Prolaris® as most clinically significant prognostic parameter of outcomes at time of diagnosis, identifying men...
BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a Potential Treatment for Agitation and Opioid Withdrawal Symptoms
Live webcast to be held on February 19th from 11:00 am ET to 2:00 pm ETNEW HAVEN, Conn., Feb. 12,...
Vapotherm to Participate in Fireside Chat at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and...
tFRWD launches COVID-19 PCR self-test to do at home (saliva based)
In partnership with local distributor DIVISIONCARE, tFRWD is ready to supply large numbers of the test-kits to the Portuguese. The...